Cilostazol suppresses angiotensin II-induced apoptosis in endothelial cells

Patients with essential hypertension undergo endothelial dysfunction, particularly in the conduit arteries. Cilostazol, a type III phosphodiesterase inhibitor, serves a role in the inhibition of platelet aggregation and it is widely used in the treatment of peripheral vascular diseases. Previous stu...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Mol Med Rep
Egile Nagusiak: SHI, MIAO-QIAN, SU, FEI-FEI, XU, XUAN, LIU, XIONG-TAO, WANG, HONG-TAO, ZHANG, WEI, LI, XUE, LIAN, CHENG, ZHENG, QIANG-SUN, FENG, ZHI-CHUN
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: D.A. Spandidos 2016
Gaiak:
Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4768974/
https://ncbi.nlm.nih.gov/pubmed/26862035
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mmr.2016.4881
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak